Return Energy (CVE:RTN) Earning Very Critical Press Coverage, InfoTrie Reports

Share on StockTwits

News headlines about Return Energy (CVE:RTN) have trended very negative recently, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Return Energy earned a news impact score of -3.00 on their scale. InfoTrie also gave news articles about the company an news buzz score of 10 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock’s share price in the near future.

Shares of RTN opened at C$0.03 on Friday. The company has a current ratio of 17.91, a quick ratio of 17.88 and a debt-to-equity ratio of 168.12. The firm has a market capitalization of $78.32 million and a P/E ratio of -3.00. The stock’s fifty day simple moving average is C$0.03 and its 200 day simple moving average is C$0.04. Return Energy has a twelve month low of C$0.01 and a twelve month high of C$0.08.

About Return Energy

Return Energy Inc engages in the exploration for, development, and production of petroleum and natural gas properties in the Western Canadian Sedimentary Basin. The company holds interests in the producing oil and gas assets in the Peace River Arch Area of Northwest Alberta. It primarily owns and operates a 100% interest in the Rycroft gas plant and associated gathering system.

Featured Story: What is the Fibonacci sequence?

Receive News & Ratings for Return Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Return Energy and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Usio’s  Buy Rating Reaffirmed at LADENBURG THALM/SH SH
Usio’s Buy Rating Reaffirmed at LADENBURG THALM/SH SH
Navidea Biopharmaceuticals’  “Buy” Rating Reiterated at Maxim Group
Navidea Biopharmaceuticals’ “Buy” Rating Reiterated at Maxim Group
PAVmed  Stock Rating Reaffirmed by Maxim Group
PAVmed Stock Rating Reaffirmed by Maxim Group
Williams-Sonoma  Upgraded to B- by TheStreet
Williams-Sonoma Upgraded to B- by TheStreet
Ross Stores  Stock Rating Lowered by TheStreet
Ross Stores Stock Rating Lowered by TheStreet
Neutral Press Coverage Somewhat Likely to Impact Morgan Stanley  Share Price
Neutral Press Coverage Somewhat Likely to Impact Morgan Stanley Share Price


© 2006-2020 Ticker Report